| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |